Madopar monotherapy ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 6 | パーキンソン病 | 1 |
6. パーキンソン病
臨床試験数 : 2,298 / 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04968613 (ClinicalTrials.gov) | January 1, 2018 | 27/6/2021 | Dopaminergic Mechanism of Memory Impairment in Parkinson's Disease | Dopaminergic Mechanism of Temporal Working Memory Impairment in Parkinson's Disease | Parkinson Disease;Memory Impairment | Drug: Madopar monotherapy;Drug: senfrol monotherapy;Drug: placebo monotherapy | Peking University Third Hospital | Chinese Academy of Sciences | Recruiting | 50 Years | 80 Years | All | 150 | Phase 4 | China |